/C O R R E C T I O N — Vector Sciences & Therapeutics/

/C O R R E C T I O N -- Vector Sciences & Therapeutics/

PR Newswire

MEQUON, Wis., May 11, 2026

In the news release, Vector Science & Therapeutics Enters Three-Year Development and Manufacturing Agreement with MPP Group LLC, issued 11-May-2026 by Vector Sciences & Therapeutics over PR Newswire, we are advised by the company that changes have been made. The complete, corrected release follows:

Vector Science & Therapeutics Enters Three-Year Development and Manufacturing Agreement with MPP Group LLC

/C O R R E C T I O N — Vector Sciences & Therapeutics/

Other newsrooms on this story

Related reading

/C O R R E C T I O N — Radial Health, Inc./

/C O R R E C T I O N — Pegasus/PBN Pharmacal/

NanoViricides Announces Closing of ~$2 Million Registered Direct Offering

Market News – Business Wire | Morningstar

Onco-Innovations Reports Continued Advancement of Key Materials Used in the…

Immunovant’s potential autoimmune ‘blockbuster’; Wave’s RNA editing update